Luteinizing hormone (LH) is a hormone with a vital role in the endocrine system, particularly regarding reproductive health. Understanding LH and its functions is crucial for comprehending various aspects of fertility, menstrual cycles, and hormonal balance in both men and women.
Luteinizing Hormone (LH) is created by your pituitary gland in the brain. For women, LH is the key player in the luteal phase of the menstrual cycle, causing ovulation - the release of a mature egg from the ovary.
For men, LH is responsible for the production of testosterone, a hormone necessary for the development of male secondary sexual characteristics and sperm production.
In this article, we will delve into the definition and characteristics of LH, exploring its structure and functions within the body. Additionally, we will examine the role of LH in female and male reproductive health, and how LH levels are tested. Furthermore, we will explore methods to increase LH levels naturally or through medical interventions, as well as what low LH levels may indicate for an individual's health.
Through this exploration, readers will gain a deeper understanding of the importance of LH and its implications for overall well-being.
LH is a crucial hormone produced by the anterior pituitary gland, a pea-sized structure located in the brain. Structurally, LH is a glycoprotein hormone composed of an alpha and beta subunit.
In both men and women, LH is an important hormone in regulating reproductive function. Through a complex series of messages sent along the hypothalamic-pituitary-gonadal (HPG) axis, LH helps stimulate and regulate key reproductive functions. LH exerts its effects primarily on the gonads—specifically, the ovaries in females and the testes in males.
LH is primarily secreted by the anterior pituitary gland in response to signals from the hypothalamus. Within the anterior pituitary, specialized cells known as gonadotropes are responsible for synthesizing and releasing LH in response to regulatory signals from the hypothalamus.
The hypothalamus produces and releases gonadotropin-releasing hormone (GnRH), which acts as the primary stimulator of LH secretion. GnRH is transported via the hypothalamic-pituitary portal system to the anterior pituitary, where it binds to receptors on gonadotropes, triggering the synthesis and release of LH into the bloodstream.
Once in circulation, LH travels to the gonads—ovaries in females and testes in males—where it exerts its effects on reproductive function.
The relationship between the hypothalamus, the pituitary gland, and the ovaries or testes is called the hypothalamic-pituitary-gonadal (HPG) axis.
The HPG axis is a complex regulatory system in the body responsible for coordinating the production and release of reproductive hormones, with the hypothalamus releasing gonadotropin-releasing hormone (GnRH), stimulating the pituitary gland to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn act on the gonads to regulate the synthesis of sex hormones and gametogenesis.
The production and secretion of luteinizing hormone (LH) are tightly regulated by a complex feedback system that controls the HPG axis.
GnRH, produced by hypothalamic neurons, stimulates the synthesis and release of LH from the anterior pituitary in response to various stimuli, including changes in sex steroid hormone levels and environmental factors in the blood.
GnRH secretion occurs in a pulsatile manner, with the frequency and amplitude of pulses influencing LH release. Specifically, negative feedback mechanisms play a crucial role in regulating LH secretion.
In men, LH secretion is primarily regulated by negative feedback from testosterone levels, where high testosterone levels inhibit LH production via the hypothalamic-pituitary-gonadal axis.
In women, LH secretion is tightly regulated by the pulsatile release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which stimulates LH release from the pituitary gland, particularly during the mid-menstrual cycle surge, triggering ovulation and promoting the development of the corpus luteum.
In females, the surge of LH triggers the rupture of the mature ovarian follicle, releasing the egg into the fallopian tube during ovulation. Additionally, LH stimulates the production of progesterone by the corpus luteum, which is crucial for maintaining the uterine lining during the menstrual cycle.
In males, LH stimulates the Leydig cells in the testes to produce testosterone, which is essential for the development and maintenance of male reproductive tissues and secondary sexual characteristics.
Overall, LH plays a central role in regulating the menstrual cycle in females and spermatogenesis and testosterone production in males.
Along with follicle-stimulating hormone (FSH), LH is a gonadotropin that is crucial to regulating the reproductive system.
Upon secretion, LH acts on the gonads—specifically, the ovaries in females and the testes in males—where it stimulates various processes essential for reproductive function. LH secretion is tightly regulated by gonadotropin-releasing hormone (GnRH) from the hypothalamus, forming a complex feedback loop that ensures proper reproductive health in both men and women.
In females, LH surge triggers ovulation, the release of a mature egg from the ovary, and supports the development of the corpus luteum, which produces progesterone necessary for the preparation and maintenance of the uterine lining for potential implantation. Any disruptions in LH levels or function can lead to reproductive disorders, such as infertility, menstrual irregularities, and hormonal imbalances.
In female reproductive health, luteinizing hormone (LH) plays a pivotal role in regulating the menstrual cycle and ovulation. During the menstrual cycle, LH levels surge in response to rising estrogen levels, triggering the release of a mature egg from the ovary during ovulation.
This pulsatile rise in LH, often referred to as the LH surge, stimulates the rupture of the ovarian follicle, releasing the egg into the fallopian tube where it can be fertilized by sperm.
LH is also essential for the development and maintenance of the corpus luteum, a temporary endocrine structure that forms from the remnants of the ovarian follicle after ovulation.
The corpus luteum produces progesterone, which is crucial for preparing the uterine lining for potential implantation of a fertilized egg and supporting early pregnancy. If fertilization does not occur the corpus luteum regresses, leading to a decline in LH levels and the start of a new menstrual cycle.
LH plays a critical role in the reproductive health of women by regulating ovulation and progesterone production during the luteal phase of the menstrual cycle.
Luteinizing hormone (LH) plays a crucial role in male reproductive health by acting on Leydig cells in the testes to stimulate the production and secretion of testosterone.
Upon binding to its receptors on Leydig cells, LH triggers the synthesis and release of testosterone, which is essential for the development and maintenance of male reproductive organs, including the testes and accessory glands.
Testosterone is also crucial for the initiation and maintenance of spermatogenesis, the process of sperm production, as well as the development of secondary sexual characteristics such as facial hair growth, deepening of the voice, and muscle mass.
Additionally, LH acts synergistically with follicle-stimulating hormone (FSH) to support optimal sperm production and maturation within the seminiferous tubules of the testes, ensuring fertility and overall reproductive function in men.
During fetal development, luteinizing hormone (LH) and human chorionic gonadotropin (hCG) are pivotal hormones for both male and female sexes, with their levels fluctuating throughout gestation.
In male fetuses hCG initially dominates, contributing significantly to testosterone production by Leydig cells before LH takes over around weeks 15 to 20. Anencephalic male fetuses lacking LH exhibit normal reproductive tract development initially, but struggle with external genitalia development as hCG levels decline.
In contrast, female fetuses experience higher peak levels of LH, likely due to lack of negative feedback from testosterone than male fetuses experience. Female fetuses have lower levels of gonadal hormones in utero because their reproductive tract development is less reliant on gonadal hormone levels. Females have less steroidogenesis until after delivery, as LH receptors in the ovaries only express later in gestation.
After delivery, both male and female infants experience a surge in LH levels due to estrogen withdrawal from the mother, followed by a gradual decline to low basal levels until prepuberty.
During puberty, there is a gradual increase in LH secretion, initially nocturnal, then transitioning to a pulsatile pattern throughout the day, stimulating gonadal steroidogenesis essential for maturation in males and females.
Luteinizing hormone (LH) levels can be assessed through various testing options, including blood tests and urine tests.
Blood tests are the most common method and involve drawing a blood sample, typically from a vein in the arm, which is then analyzed in a laboratory to measure LH levels.
Urine tests, on the other hand, often utilize LH detection kits that allow individuals to test their urine at home. These kits detect LH surge, which is particularly useful for tracking ovulation in women.
Additionally, LH levels can also be assessed through saliva tests, although these are less common. Cycle mapping tests that monitor hormone levels throughout a woman’s entire cycle tend to utilize urine or saliva tests.
For blood LH testing, a healthcare professional will typically draw a blood sample, usually in the morning when hormone levels are most stable. The sample is then sent to a laboratory for analysis, where LH levels are measured using specialized equipment.
Urine LH testing can be done at home using LH detection kits, which involve collecting a urine sample and applying it to the test strip according to the manufacturer's instructions. Results are usually available within minutes.
Saliva LH testing involves collecting a saliva sample using a specialized kit to assess LH levels; while it does correlate with serum levels to demonstrate an LH surge, this method is less commonly used and may require specific instructions for collection and analysis. Samples are typically shipped to a lab for analysis. [7.]
LH reference ranges vary depending on age, sex, and sample type. Additionally, reference ranges may vary among labs.
A typical reference range for LH in blood is [8., 11.]
Adults:
Male: 1.24-7.8 IU/L
Female:
Follicular phase: 1.68-15 IU/L
Ovulatory peak : 21.9-56.6 IU/L
Luteal phase: 0.61-16.3 IU/L
Postmenopause: 14.2-52.3 IU/L
Child (age 1-10 years):
Male: 0.04-3.6 IU/L
Female: 0.03-3.9 IU/L
Typical reference ranges indicating an LH surge in urine testing is about 20 to 100 mIU/ml. [14.] Following the LH surge, ovulation was most commonly detected during ultrasonography 20+/- 3 hours later. [14.]
Questions regarding reference ranges for salivary testing of LH should be directed to the companies offering them.
LH testing plays a crucial role in diagnosing and monitoring various reproductive disorders and conditions.
In women, LH levels are often measured alongside other hormones like follicle-stimulating hormone (FSH) to assess ovarian function, predict ovulation, and evaluate fertility issues. Elevated or suppressed LH levels may indicate conditions such as polycystic ovary syndrome (PCOS), ovarian failure, or pituitary disorders.
In men, LH testing is used to evaluate testicular function and diagnose conditions such as hypogonadism and infertility. Abnormal LH levels in men may suggest problems with the hypothalamus, pituitary gland, or testes, warranting further investigation and treatment.
Specific clinical conditions associated with alterations in LH from expected values include:
Low luteinizing hormone (LH) levels can stem from various factors, including hypothalamic or pituitary dysfunction, primary ovarian failure, or certain medications.
In women, low LH levels may indicate hypothalamic amenorrhea, a condition characterized by reduced GnRH secretion due to stress, excessive exercise, or low body weight. Similarly, pituitary disorders such as hypopituitarism can lead to decreased LH production, disrupting the normal menstrual cycle and fertility.
In men, low LH levels may signal hypogonadotropic hypogonadism, where insufficient LH secretion results in impaired testosterone production and testicular function. Additionally, certain medications like corticosteroids or opioids can suppress LH secretion, leading to hormonal imbalances and reproductive issues.
The clinical implications of low LH levels depend on the underlying cause and its impact on reproductive health.
In women, addressing factors contributing to hypothalamic dysfunction such as stress reduction, adequate nutrition, or hormonal therapy, may help restore normal LH secretion and menstrual function.
Similarly, for men with hypogonadotropic hypogonadism, treatment often involves hormone replacement therapy to supplement deficient LH levels and stimulate testosterone production.
However, the treatment approach varies based on individual factors such as age, overall health, and fertility goals. Regular monitoring of LH levels through blood tests is essential to assess treatment efficacy and adjust interventions accordingly, aiming to optimize reproductive outcomes and overall well-being.
Diet: maintain a balanced diet rich in essential nutrients, including antioxidants, vitamins, and minerals, which can support overall reproductive health. Additionally, eating enough calories is essential to maintain hypothalamic production of GnRH. [9.]
Exercise: engage in regular exercise to promote blood circulation and hormone balance. [5., 15.]
Stress: manage stress through relaxation techniques such as meditation, yoga, or deep breathing exercises, as stress can negatively impact hormone levels and impair hypothalamic release of GnRH. [13.]
Sleep: get adequate sleep to ensure proper hormone regulation and overall well-being. [3.]
Acupuncture: consider acupuncture or acupressure, which may help regulate hormone levels and improve reproductive function. [2.]
Herbal Support: explore herbal supplements such as vitex (chasteberry) or red clover which are believed to support hormonal balance and ovarian function. [1.]
Healthy Weight Management: maintain a healthy weight, as obesity or being underweight can disrupt hormone levels and fertility. [4.]
Avoid Endocrine-Disrupting Chemicals: limit exposure to environmental toxins and endocrine-disrupting chemicals found in certain plastics, pesticides, and personal care products, as they can interfere with hormone regulation. [12.]
Consult with a healthcare provider or naturopathic doctor for personalized recommendations and guidance on natural therapies to support normal LH cycling.
Click here for specific tests to assess LH levels in men and women.
[1.] Akbaribazm M, Goodarzi N, Rahimi M. Female infertility and herbal medicine: An overview of the new findings. Food Sci Nutr. 2021 Aug 15;9(10):5869-5882. doi: 10.1002/fsn3.2523. PMID: 34646552; PMCID: PMC8498057.
[2.] Chen BY. Acupuncture normalizes dysfunction of hypothalamic-pituitary-ovarian axis. Acupunct Electrother Res. 1997;22(2):97-108. doi: 10.3727/036012997816356734. PMID: 9330669.
[3.] Chidambaram S, Qoronfleh MWalid, Shivalingaiah S, et al. Sleep and Gonadotrophin Hormones. International Journal of Nutrition, Pharmacology, Neurological Diseases. 2021;11(1):17. doi:https://doi.org/10.4103/ijnpnd.ijnpnd_97_20
[4.] Goldsammler M, Merhi Z, Buyuk E. Role of hormonal and inflammatory alterations in obesity-related reproductive dysfunction at the level of the hypothalamic-pituitary-ovarian axis. Reprod Biol Endocrinol. 2018 May 9;16(1):45. doi: 10.1186/s12958-018-0366-6. PMID: 29743077; PMCID: PMC5941782.
[5.] Jurkowski JE, Jones NL, Walker C, Younglai EV, Sutton JR. Ovarian hormonal responses to exercise. J Appl Physiol Respir Environ Exerc Physiol. 1978 Jan;44(1):109-14. doi: 10.1152/jappl.1978.44.1.109. PMID: 627490.
[6.] Leiva RA, Bouchard TP, Abdullah SH, Ecochard R. Urinary Luteinizing Hormone Tests: Which Concentration Threshold Best Predicts Ovulation? Front Public Health. 2017 Nov 28;5:320. doi: 10.3389/fpubh.2017.00320. Erratum in: Front Public Health. 2018 Nov 30;6:345. PMID: 29234665; PMCID: PMC5712333.
[7.] Loewit K, Huber J, Ortlieb A, Kraft HG, Widhalm R, Wolfram G. Speichel-LH als Ovulationsindikator: Vergleich zwischen Speichel-LH, Serum-LH und Ultraschallbefund [Salivary LH as an ovulation indicator: comparison between salivary LH, serum LH and ultrasonic findings]. Geburtshilfe Frauenheilkd. 1987 Nov;47(11):800-2. German. doi: 10.1055/s-2008-1036050. PMID: 3319762.
[8.] Luteinizing Hormone: Reference Range, Interpretation, Collection and Panels. eMedicine. Published online May 20, 2021. https://emedicine.medscape.com/article/2089268-overview
[9.] Miller KK. Endocrine dysregulation in anorexia nervosa update. J Clin Endocrinol Metab. 2011 Oct;96(10):2939-49. doi: 10.1210/jc.2011-1222. PMID: 21976742; PMCID: PMC3200238.
[10.] Nedresky D, Singh G. Physiology, Luteinizing Hormone. [Updated 2022 Sep 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539692/
[11.] Pagana KD, Pagana TJ, Pagana TN. Mosby's Diagnostic & Laboratory Test Reference. 14th ed. St. Louis, MO: Elsevier; 2019. 593.
[12.] Plunk EC, Richards SM. Endocrine-Disrupting Air Pollutants and Their Effects on the Hypothalamus-Pituitary-Gonadal Axis. Int J Mol Sci. 2020 Dec 2;21(23):9191. doi: 10.3390/ijms21239191. PMID: 33276521; PMCID: PMC7731392.
[13.] Son YL, Ubuka T, Tsutsui K. Regulation of stress response on the hypothalamic-pituitary-gonadal axis via gonadotropin-inhibitory hormone. Front Neuroendocrinol. 2022 Jan;64:100953. doi: 10.1016/j.yfrne.2021.100953. Epub 2021 Oct 29. PMID: 34757094.
[14.] Su HW, Yi YC, Wei TY, Chang TC, Cheng CM. Detection of ovulation, a review of currently available methods. Bioeng Transl Med. 2017 May 16;2(3):238-246. doi: 10.1002/btm2.10058. PMID: 29313033; PMCID: PMC5689497.
[15.] Williams NI, McArthur JW, Turnbull BA, Bullen BA, Skrinar GS, Beitins IZ, Besser GM, Rees LH, Gilbert I, Cramer D, et al. Effects of follicular phase exercise on luteinizing hormone pulse characteristics in sedentary eumenorrhoeic women. Clin Endocrinol (Oxf). 1994 Dec;41(6):787-94. doi: 10.1111/j.1365-2265.1994.tb02794.x. PMID: 7889615.